Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
26 mars 2018 07h30 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics, Inc. Chief Executive Officer Steps Down
05 févr. 2018 08h12 HE
|
Cancer Genetics, Inc.
• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision...
Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
17 janv. 2018 07h30 HE
|
Cancer Genetics, Inc.
- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and Resistance Mechanisms RUTHERFORD, N.J., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer...
Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
28 déc. 2017 07h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific
19 déc. 2017 07h30 HE
|
Cancer Genetics, Inc.
The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer (NSCLC) Global NSCLC diagnostic market projected to reach $3.65 billion by 2024 RUTHERFORD,...
Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis
11 déc. 2017 07h30 HE
|
Cancer Genetics, Inc.
Study Presented at the 59th American Society of Hematology (ASH) Annual MeetingStudy focused on DLBCL (Diffuse Large B-Cell Lymphomas) RUTHERFORD, N.J., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Cancer...
Cancer Genetics Prices $7 Million Registered Direct Offering
08 déc. 2017 08h58 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics to Participate in Upcoming Investor Conferences
30 nov. 2017 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India
29 nov. 2017 08h02 HE
|
Cancer Genetics, Inc.
Collaboration with India’s premier professional oncology organization, the Indian Cooperative Oncology Network (ICON)Goal to bring CGI’s global expertise in clinical diagnostic assay development and...
Cancer Genetics and Indian Cooperative Oncology Network (ICON) Collaborate to Reduce Alarmingly Increasing Cancer Mortality Rates
29 nov. 2017 08h00 HE
|
Cancer Genetics, Inc.
Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a drug development partner to optimize clinical outcomes for cancer patients; Aim to develop educational and...